GLAXO NSE · Healthcare · Pharmaceuticals & Biotechnology
GlaxoSmithKline Pharmaceuticals Limited
₹2,815.70 NSE close, 25 Sep 2026
Data as of 10 sources, each card shows its own date MF: Aug 2026 portfolios (monthly), 20 AMCs Shares outstanding and close: NSE, 25 Sep 2026 Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collected Deals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026 SLBM: NSE, 25 Sep 2026 · 30 days collected MTF: NSE, 24 Sep 2026 · 29 days collected Flags: NSE, 25 Sep 2026 FPI: Shareholding pattern as of 30 Jun 2026, filed 16 Jul 2026 Pledge: Shareholding pattern as of 30 Jun 2026 Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF houses FPIs Insider and promoter Bulk and block deals Promoter pledge SLBM borrowing MTF book Delivery Red flags
MF holding, % of equity
3.06% ▲ +0.03 pp
Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes
FPI holding, % of equity
4.79%
as of 30 Jun 2026
Fund houses holding
8 ▼ −1
0 entered, 1 exited · Aug 2026 · index funds hidden
Promoter pledge
0.00%
as of 30 Jun 2026
What changed
8 tracked fund houses held GLAXO in Aug 2026. Groww Mutual Fund exited.
All tracked schemes together held 51.86 lakh shares, 3.06% of equity, worth ₹1,582 cr at the end of Aug 2026.
Index and arbitrage funds held 0.16% of equity; they are left out of the fund-house counts.
MF houses Aug 2026
8 ▼ −1 m/m
Top buyer Nippon India Mutual Fund, +0.12% of equity. Top seller ICICI Prudential Mutual Fund, −0.13% of equity. Index and arbitrage funds hidden.
Named FPIs at 1% or more as of 30 Jun 2026
4.79%
FPI category I + II, % of total shares · 0 named at 1% or more
No FPI held 1% or more of GLAXO on 30 Jun 2026.
Insider and promoter 29 Jun 2026 to 26 Sep 2026
No insider or promoter trade in GLAXO was disclosed 29 Jun 2026 to 26 Sep 2026.
Bulk and block deals 25 Sep 2026
No bulk or block deals in GLAXO on 25 Sep 2026.
Promoter pledge as of 30 Jun 2026
0.00%
of promoter holding · 0.00% of total shares
Promoters had pledged 0 of their 12.71 cr shares on 30 Jun 2026.
SLBM borrowing 25 Sep 2026
NSE listed no SLBS open position for GLAXO on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026. No SLBM trades in GLAXO on 25 Sep 2026.
MTF book 24 Sep 2026
66,193 sh ▼ −870 vs 23 Sep 2026
percentile 86 of 29 days collected · ₹18.3 cr financed
66,193 shares, 0.04% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 86 of 29 days collected.
Delivery 25 Sep 2026
45.4% ▼ −8.1 pp vs 20-day average
20-day average 53.5% · percentile 30 of 30 days collected
45.4% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 53.5%; that day sits at percentile 30 of 30 days collected.
Red flags 25 Sep 2026
No F&O
GLAXO has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed GLAXO under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.